Does Ginkgo Sleep Quality Randomized Trial work?

Updated July 2026

Quick Answer

Ginkgo Sleep Quality Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: Conclusion Current RCT evidence shows inconsistent and limited findings, and no firm conclusions can be drawn about whether any OTC therapy provides symptomatic benefit.

Key Takeaways

  • 01Conclusion Current RCT evidence shows inconsistent and limited findings, and no firm conclusions can be drawn about whether any OTC therapy provides symptomatic benefit. [Menon R (2026)]
  • 02Level of evidence 1 (Systematic review of RCTs with low-moderate heterogeneity). [Menon R (2026)]
  • 03Objective To review the effectiveness of over-the-counter (OTC) treatments in reducing tinnitus symptom severity as measured by the Tinnitus Handicap Inventory (THI) in randomized controlled trials. [Menon R (2026)]
  • 04Methods A comprehensive search was conducted in PubMed, Embase, Cochrane CENTRAL, ClinicalTrials.gov, and WHO ICTRP through March 2025. [Menon R (2026)]
The current Migaku evidence database contains 2 reusable source documents for Ginkgo Sleep Quality Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove. - Conclusion Current RCT evidence shows inconsistent and limited findings, and no firm conclusions can be drawn about whether any OTC therapy provides symptomatic benefit. [Menon R (2026); evidence level 1] - Level of evidence 1 (Systematic review of RCTs with low-moderate heterogeneity). [Menon R (2026); evidence level 1] - Objective To review the effectiveness of over-the-counter (OTC) treatments in reducing tinnitus symptom severity as measured by the Tinnitus Handicap Inventory (THI) in randomized controlled trials. [Menon R (2026); evidence level 1] - Methods A comprehensive search was conducted in PubMed, Embase, Cochrane CENTRAL, ClinicalTrials.gov, and WHO ICTRP through March 2025. [Menon R (2026); evidence level 1] - These limitations have catalyzed an increased global focus on nutraceuticals and phytomedicines possessing multimodal biological activities that transcend mere monoamine reuptake inhibition. [Li Xikun (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Effectiveness of Over-The-Counter Treatments for Tinnitus Symptom Relief: A Systematic Review.
  2. Rhodiola rosea , Ginkgo biloba , and Ashwagandha as novel antidepressant supplements: converging monoaminergic, neurotrophic, anti-inflammatory, and brain health pathways in depressive disorders